期刊文献+

免疫抑制小鼠侵袭性肺烟曲霉菌感染模型建立的研究 被引量:2

Establishment of animal model of invasive pulmonary aspergillosis in immunosuppressed mice
下载PDF
导出
摘要 目的:建立免疫抑制小鼠侵袭性烟曲霉菌感染模型,为感染性疾病的研究和治疗提供科学依据。方法:给予昆明种健康小鼠腹腔内一次性注射环磷酰胺(CY)200mg/kg,观察其对小鼠一般状况和白细胞数的影响。4d后,经小鼠双侧鼻孔滴注烟曲霉菌孢子悬液30μl引起侵袭性肺烟曲霉菌病(IPA),并于不同时间点处死小鼠,进行组织培养及病理分析。结果:环磷酰胺注射后,小鼠白细胞数量明显降低,病理切片可见免疫抑制小鼠感染烟曲霉菌后肺组织大量烟曲霉菌聚集,组织坏死,形成肺脓肿。结论:成功建立了免疫抑制小鼠侵袭性肺烟曲霉菌病动物模型,为研究人类烟曲霉菌病的致病机制、诊断和防治奠定了实验基础。 Objective:To establish an experimental animal model of invasive pulmonary aspergillosis in immunosuppressed mice for providing scientific evidence with the research and treatment of such infectious disease. Methods:The healthy mice of Kunming species were given intraperitoneal injection of cyclophosphamide(CY) at single dose of 200 mg/kg,followed by observing the effects on general state and leukocyte count of mice. After 4 days,the aspergillus fumigatus conidia suspension(30 μl/mouse) were dropped into the nares of each mouse to cause invasive pulmonary aspergillosis(IPA),and the mice were killed at different time point for tissue culturing and pathologic examination. Results:After injection of CY,the leukocyte counts were reduced greatly and the pathological findings revealed massive concentration of aspergillus fumigatus in the lung tissues of the immunosuppressed mice after the infection,with necrotic tissues and formation of pulmonary abscess. Conclusion:An experimental animal model of invasive pulmonary aspergillosis was successfully established,which lays a foundation for the study of aspergillosis pathogenesis,diagnosis and prevention.
作者 潘中武 董群
出处 《皖南医学院学报》 CAS 2010年第4期246-249,共4页 Journal of Wannan Medical College
基金 芜湖市科技计划年度重点项目(2008510)
关键词 烟曲霉菌 免疫抑制 模型 aspergillus fumigatus immunosuppression model
  • 相关文献

参考文献8

二级参考文献20

  • 1杨琼,宋祥福,王桂云.系统性白色念珠菌感染小鼠动物模型的研究[J].东北师大学报(自然科学版),2005,37(2):86-89. 被引量:14
  • 2张婴元.侵袭性真菌感染的正确诊断和合理治疗是当前值得重视的问题[J].中国感染与化疗杂志,2007,7(1):1-3. 被引量:28
  • 3唐晓丹,吴菊芳.器官移植受者曲霉感染诊治进展[J].中国感染与化疗杂志,2007,7(1):63-67. 被引量:3
  • 4刘香梅,张钰,闵凡贵,赵维波,刘忠华,黄韧.环磷酰胺对近平滑念珠菌感染小鼠白细胞的影响[J].实验动物与比较医学,2007,27(2):116-118. 被引量:4
  • 5MAERTENS J, VREBOS M, BOOGAERTS M. Assessing risk factors for systemic fungal infections [ J ]. Eur J Cancer Care, 2001,10(1) : 56 - 62.
  • 6MOSER SA, DOMER JE. Effects of Cyclophospdamide on murine candidiasis[ J ]. Infect Immun, 1980,27 (2) : 376 - 386.
  • 7Wenzel R,Brewer TF,Bulzler JP,et al.Fungi,A guide to infection control in the hospital(2nd Edition),international society for infection diseases[M].Boston,MA.USA,BC Decker Inc Hamilton.London,2002,157-159.
  • 8Hajjeh RA,Sofair AN,Harrison LH,et al.Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program[J].Journal of clinical microbiology,2004,42:1519-1527.
  • 9Hope W,Morton A,Eisen DP.Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use[J].J Hosp Infect,2002,50:56-65.
  • 10Stephen A.Moser and Judith E.Domer.,Effects of Cyclophosphamide on Murine Candidiasis[J].Infection and Immunity,1980,27:376-386.

共引文献52

同被引文献16

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部